US4310528A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Process for the preparation of bis-indole alkaloids and acid-addition salts thereof and methods of treating tumors with bis-indole alkaloids
Assignee: Richter Gedeon Vegyeszeti Gyar Nyrt
•
Filing: 1980-04-08
•
Granted: 1982-01-12
•
Expires: 2000-04-08
Abstract
Abstract A proces for the oxidation of vinblastine, leurosine or an acid addition salt thereof which comprises reacting the vinblastine, leurosine or acid addition salt thereof with chromic acid or an alkali metal dichromate, at a temperature of from -30 °C to 90°C in the presence of a water immiscible organic solvent in which alkaloids are readily soluble, acetic anhydride and optionally glacial acetic acid and/or up to 10% by volume of ethanol based on the volume of the water-immiscible organic solvent; thereafter adjusting the pH of the reaction mixture to from 8 to 10; and isolating the products obtained and/or subjecting the said products to further treatment.The specification also describes new bis-indole-alkaloids, pharmaceutical compositions containing them and their use as anti-tumour agents.
Inventors
- 👤 Karola Jovanovics
- 👤 Sandor Gorog
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-06 01:46
CPC Classifications
C; C07; C07D; C07D519/00; C07D519/04; A; A61; A61P; A61P35/00
Claims Analysis
Total Claims: 9
Claim 1
Independent Claim
37 words
A method of treating leukemia, carcinoma, or lymphoma in an animal which comprises the step of administering to said animal a pharmaceutically effective amount of the formula (Ia) ##STR3## or a pharmaceutically acceptable acid addition salt thereof.
Claim 2
Independent Claim
37 words
A method of treating leukemia, carcinoma, or lymphoma in an animal which comprises the step of administering to said animal a pharmaceutically effective amount of the formula (Ia) ##STR3## or a pharmaceutically acceptable acid addition salt thereof.
Claim 3
Dependent Claim
170 words
A process for the preparation of a compound of the formula (Ia) ##STR4## or a pharmaceutically acceptable acid addition salt thereof, which comprises the steps of: (a) oxidizing vinblastine or a pharmaceutically acceptable acid addition salt thereof with chromic acid or an alkali metal dichromate at a temperature of -90° C. to -45° C. in the presence of a water-immiscible organic solvent in which alkaloids are readily soluble, acetic anhydride, glacial acetic acid, and ethanol in an amount up to 10% by volume of the water-immiscible organic solvent; (b) adjusting the pH of the oxidation reaction of step (a) to a range of 8 to 10 by adding an aqueous alkaline solution thereby forming an organic phase containing alkaloids and an aqueous phase at a temperature no higher than 50° C.; (c) separating the aqueous phase from the organic phase to leave an alkaloid mixture and driving the water-immiscible organic solvent therefrom; and (d) separating the desired product from the alkaloid mixture leaving behind a residue containing vincristine and N-desmethyl-vinblastine.
Claim 4
Dependent Claim
170 words
A process for the preparation of a compound of the formula (Ia) ##STR4## or a pharmaceutically acceptable acid addition salt thereof, which comprises the steps of: (a) oxidizing vinblastine or a pharmaceutically acceptable acid addition salt thereof with chromic acid or an alkali metal dichromate at a temperature of -90° C. to -45° C. in the presence of a water-immiscible organic solvent in which alkaloids are readily soluble, acetic anhydride, glacial acetic acid, and ethanol in an amount up to 10% by volume of the water-immiscible organic solvent; (b) adjusting the pH of the oxidation reaction of step (a) to a range of 8 to 10 by adding an aqueous alkaline solution thereby forming an organic phase containing alkaloids and an aqueous phase at a temperature no higher than 50° C.; (c) separating the aqueous phase from the organic phase to leave an alkaloid mixture and driving the water-immiscible organic solvent therefrom; and (d) separating the desired product from the alkaloid mixture leaving behind a residue containing vincristine and N-desmethyl-vinblastine.
Claim 5
Dependent Claim
29 words
The process defined in claim 2, step (a), wherein the ethanol is present in an amount between 0.1 to 3% relative to the volume of the water-immiscible organic solvent.
Claim 6
Dependent Claim
18 words
The process defined in claim 2, step (a), wherein the water-immiscible organic solvent is chloroform or methylene chloride.
Claim 7
Dependent Claim
20 words
The process defined in claim 2, step (b), wherein the aqueous alkaline solution is an aqueous solution of ammonium hydroxide.
Claim 8
Dependent Claim
22 words
The process defined in claim 2, step (d), wherein the desired product is separated from the alkaloid product by thin layer chromatography.
Claim 9
Dependent Claim
27 words
The process defined in claim 2, further comprising the steps of: (e) separating the vincristine from the N-desmethyl-vinblastine; and (f) formylating the N-desmethyl-vinblastine to yield additional vincristine.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1985-01-11 | 1985-07-13 | 1986-01-12 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1989-01-11 | 1989-07-13 | 1990-01-12 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1993-01-11 | 1993-07-13 | 1994-01-12 | $7700.00 | Window Closed / Lapsed |